-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

637. Myelodysplastic Syndromes — Clinical and Epidemiological: Poster III Clinically Relevant Abstract

Program: Oral and Poster Abstracts
Type: Poster
Monday, December 13, 2021: 6:00 PM-8:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Guillermo Montalban-Bravo, MD1, Elias J. Jabbour2, Zeev E. Estrov, MD1, Tapan M. Kadia, MD1, Farhad Ravandi, MB Bs1, Kelly S. Chien, MD1, Graciela M. Nogueras González, MPH3*, Xiao Qin Dong1*, Stefan Faderl4*, Heather Schneider, BSN, RN1*, Rosmy B. John, MSN1*, Meghan Anne Meyer, BSN, RN1*, Hagop Kantarjian, MD5 and Guillermo Garcia-Manero, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
4Jazz Pharmaceuticals, Palo Alto, CA
5The University of Texas MD Anderson Cancer Center, Houston, TX

David M Ross, MBBS, PhD, FRACP, FRCPA1*, Alejandro Arbelaez, MBBS, FRACP, FRCPA2*, Lynette C.Y. Chee, MBBS, PhD, FRACP, FRCPA3, Chun Yew Fong, MBBS, PhD4, Devendra Hiwase, MBBS, MD, FRACP, FRCPA, PhD5, George Kannourakis, MB.BS, B(Med)Sci, PhD, FRACP6, John Kwan, MBBS, FRACP, FRCPA7*, James Liang, MCBhB, FRACP, FRCPA8*, Anish Puliyayil, MD. DM. FRACP.9*, Hannah Rose, MBBS10*, Shuhying Tan, MBBS11*, Tse-Chieh Teh, MBBS, PhD, FRACP, FRCPA12*, David Alan Westerman, MBBS, FRCPA, FRACP13, Joel Wight, MBBS FRACP FRCPA14, Chris Rovaldi, MSc15*, Elissa M. Furutani, MD16, Adrienne Gaggi16*, Ying Jiang, PhD16*, Jenn Lachey, PhD16, Harveen Dhillon Natarajan, PhD16* and Claudia Ordonez, MD16*

1Department of Haematology, Flinders Medical Centre and University, Adelaide, SA, Australia
2Tweed Hospital, Brisbane, AUS
3Department of Clinical Haematology and Bone Marrow Transplant Service, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
4Department of Clinical Haematology, Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, Australia
5Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia
6Ballarat Onc. & Hem. Services, Ballarat, Australia
7Westmead Hospital, Sydney, NSW, Australia
8Middlemore Hospital, Auckland, New Zealand
9Albury Wodonga Health, Albury-Wodonga Regional Cancer Centre,, Auckland, Australia
10Barwon Health, Geelong, Australia
11St. Vincent, XX, VIC, Australia
12Box Hill Hospital, Victoria, Australia
13Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia
14Townsville University Hospital, Douglas, QLD, Australia
15NS Biopharma, Marblehead, MA
16Keros Therapeutics, Lexington, MA

Sangmin Lee, MD1, Sanjay R Mohan, MD, MSCI2, Jessica Knupp3*, Kamal Chamoun, MD3*, Igor Karasik4*, Vicky Xiang Bai3*, Kimberly Ingalls, MD, MPH3*, Fan Yang, PhD3*, Jatin J. Shah, MD3*, Michael G. Kauffman, MD, PhD3, Sharon Shacham, PhD, MBA3* and Bhavana Bhatnagar, DO5*

1Weill Cornell Medical College, New York, NY
2Department of Medicine, Division of Hematology-Oncology, Vanderbilt-Ingram Cancer Center, Nashville, TN
3Karyopharm Therapeutics Inc., Newton, MA
4Karyopharm Therapeutic Inc., Newton, MA
5Department of Hematology, The Ohio State University, Columbus, OH

Andrew M. Brunner, MD1, Elie Traer, MD, PhD2, Norbert Vey, MD3, Sebastian Scholl, MD, PhD4*, Natalia Tovar5*, Kimmo Porkka, MD, PhD6*, Rupa Narayan, MD7*, Guillermo Garcia-Manero, MD8, Steve Knapper9, Martin Wermke, MD10*, Jeroen J. Janssen, MD, PhD11, Jordi Esteve, MD, PhD12, Sun Loo, MBBS, FRACP, FRCPA13*, Mika Kontro, MD, PhD14*, Zachariah Defilipp, MD15, Andrew H. Wei, MBBS, PhD16 and Uma Borate, MD17

1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
2Oregon Health & Sciences University, Portland, OR
3Institut Paoli Clamettes, Marseille, France
4University Hospital Jena, Jena, Germany
5Amyloidosis and Myeloma Unit, Hospital Clínic, Barcelona, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain
6Helsinki University Central Hospital Cancer Center, Helsinki, Finland
7Massachusetts General Hospital Cancer Center, Boston, MA
8Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
9Cardiff University, Cardiff, United Kingdom
10Medical Faculty, NCT/UCC Early Clinical Trial Unit, Technical University Dresden, Dresden, Germany
11Amsterdam UMC, Hilversum, Netherlands
12Hospital Clínic, Barcelona, Spain
13The Alfred Hospital, Melbourne, VIC, Australia
14Department of Hematology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland
15Massachusetts General Hospital / Harvard Medical School, Boston, MA
16Department of Clinical Haematology, The Alfred Hospital, Melbourne, VIC, Australia
17The James Cancer Center, The Ohio State University, Columbus, OH

Tao Zhang, PhD1*, Paul Auer, PhD1*, Stephen R. Spellman, MBS1*, Caitrin Fretham, MPH1*, Wael Saber, MD, MS2 and Yung-Tsi Bolon, PhD1*

1CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
2CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Elliot Stieglitz, MD1,2, Mignon L. Loh, MD1,2, Julia Meyer, PhD2*, Chujing Zhang, PhD2*, Donald A Barkauskas3*, David Hall3*, Elizabeth Fox, MD4* and Brenda J. Weigel, MD, MSc5*

1Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA
2Department of Pediatrics, Benioff Children's Hospital, University of California, San Francisco, San Francisco, CA
3Children's Oncology Group, Monrovia, CA
4St. Jude Children's Research Hospital, Memphis, TN
5University of Minnesota, Minneapolis, MN

Dicte Træden, BA1,2,3*, Morten Tulstrup, MD1,2,3*, Jack Bernard Cowland, MS, PhD4*, Kirsten Grønbæk, Prof, MD, DMSc1,2,3, Mette Klarskov Andersen, MD, DMSc4 and Jakob Werner Hansen, MD, PhD1,2,3*

1Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
2Department of Hematology, Rigshospitalet, Copenhagen, Denmark
3The Danish Stem Cell Center (Danstem), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
4Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark

Tao Zhang, PhD1*, Paul Auer, PhD1*, Stephen R. Spellman, MBS1*, Caitrin Fretham, MPH1*, Yung-Tsi Bolon, PhD1* and Wael Saber, MD, MS2

1CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
2CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Michael R. Savona, MD1, James K McCloskey, MD2, Elizabeth A. Griffiths, MD3, Karen Yee, MD4, Amer M. Zeidan, MD5, Aref Al-Kali, MD6, H. Joachim Deeg, MD7, Prapti Patel, MD8, Mitchell Sabloff, MSc, MD, FRCPC9, Mary-Margaret Keating, MD, FRCPC10, Kim-Hien Dao, DO11, Nancy Zhu, MD12*, Nashat Gabrail, MD13*, Salman Fazal, MD14, Joseph Maly, MD15, Olatoyosi Odenike, MD16, Hagop Kantarjian, MD17, Amy E. DeZern, MD18, Casey L. O'Connell, MD19, Gail J. Roboz, MD20, Lambert Busque, MD21, Richard A. Wells, MD, DPhil22*, Harshad Amin, MD23*, Jasleen K. Randhawa, MD24, Brian Leber, MD25, Yong Hao, MD, PhD11*, Harold N. Keer, MD, PhD11, Mohammad Azab, MD11 and Guillermo Garcia-Manero, MD17

1Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN
2John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, NJ
3Roswell Park Comprehensive Cancer Center, New York, NY
4Princess Margaret Cancer Centre, Toronto, ON, Canada
5Yale University and Yale Cancer Center, New Haven, CT
6Mayo Clinic, Rochester, MN
7Fred Hutchinson Cancer Research Center, Seattle, WA
8University of Texas Southwestern Medical Center, Dallas, TX
9Division of Hematology, Department of Medicine, University of Ottawa and The Ottawa Hospital Research Institute, Ottawa, ON, Canada
10Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
11Astex Pharmaceuticals, Inc., Pleasanton, CA
12University of Alberta, Edmonton, AB, Canada
13Gabrail Cancer Center Research, Canton, OH
14West Penn Hospital, Allegheny Health Network, Pittsburgh, PA
15Norton Cancer Institute, Louisville, KY
16University of Chicago, Chicago, IL
17The University of Texas MD Anderson Cancer Center, Houston, TX
18Johns Hopkins University Hospital, Baltimore, MD
19USC Keck School of Medicine, University of Southern California, Los Angeles, CA
20Weill Cornell Medicine, The New York Presbyterian Hospital, New York, NY
21Research Center, Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
22Sunnybrook Health Sciences Centre, Toronto, Canada
23Boca Raton Clinical Research, Boca Raton, FL
24Houston Methodist Cancer Center, Houston
25McMaster University, Hamilton, ON, Canada

Eun-Ji Choi, MD, PhD1, Young-Uk Cho, MD2, Han-Seung Park, MD1*, Jung-Hee Lee, MD, PhD1*, Kyoo Hyung Lee, MD, PhD1*, Sang-Hyun Hwang, MD, PhD2, Seongsoo Jang, M.D., Ph.D.2, Chan-jeoung Park, MD, PhD2* and Je-Hwan Lee, MD, PhD1

1Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
2Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)

Connor M. Walsh1*, Anthony Hunter, MD2, Terra Lasho, PhD3, Christy Finke, BS3*, Rami S. Komrokji, MD4, Mithun V. Shah, MD, PhD3, Ayalew Tefferi, MD3, Abhishek A. Mangaonkar, MBBS3, Matthew T Howard, MD5*, Naseema Gangat, MBBS3, Aref Al-Kali, MD3, Najla Al Ali, MS4, Eric Padron, MD4 and Mrinal M. Patnaik, MD, MBBS3

1Mayo Clinic, Rochester, MN
2Division of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
3Division of Hematology, Mayo Clinic, Rochester, MN
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Ligen Liu1,2, Yuanmmei Zhai1*, Li Yang1*, Limin Zhao1*, Li Chang1*, Chunrong Yin1*, Yingting Lu1*, Xuewei Jiang1* and Zhizhi Zhang1*

1Department of Hematology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
2Hongqiao International Institute of Medicine, Shanghai Tongren Hospital,Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education; Shanghai JiaoTong University School of Medicine;State Key Laboratory of Experimental Hematology, Shanghai, China

Rami S. Komrokji, MD1, Tracy I. George, MD2, Harry P. Erba, MD, PhD3, Bart L. Scott, MD4, David L. Grinblatt, MD5, Jaroslaw P. Maciejewski, MD, PhD6, Gail J. Roboz, MD7, Michael R. Savona, MD8*, Guillermo Garcia-Manero, MD9, Irene S. DeGutis, PharmD10*, Pavel Kiselev10*, Edward Yu10*, Adeola Y. Makinde10* and Mikkael A. Sekeres, MD11

1Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2University of Utah and ARUP Laboratories, Salt Lake City, UT
3Hematologic Malignancies Clinic, Duke University Blood Cancer Center, Durham, NC
4Fred Hutchinson Cancer Research Center, Seattle, WA
5NorthShore University Health System, Evanston, IL
6Cleveland Clinic, Cleveland, OH
7Weill Cornell Medicine and New York-Presbyterian Hospital, New York, NY
8Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN
9The University of Texas MD Anderson Cancer Center, Houston, TX
10Bristol Myers Squibb, Princeton, NJ
11Division of Hematology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL

Shehab Fareed Mohamed, MD1*, Tareq Abuasba2*, Kelly S. Chien, MD1, Guillermo Montalban-Bravo, MD1, Faezeh Darbaniyan, PhD3*, Sherry A. Pierce, BSN, BA1*, Kelly A. Soltysiak, PhD1*, Fadi Haddad, MD1*, David McCall, MD4*, Branko Cuglievan, MD4*, Elias J. Jabbour5, Naval Daver, MD6, Tapan M. Kadia, MD7, Naveen Pemmaraju, MD1, Hagop Kantarjian, MD1 and Guillermo Garcia-Manero, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
4Division of Pediatric Hematology Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
6MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX

Ahmad Ghorab, MD, MSc1, Aref Al-Kali, MD2, Michelle A. Elliot, MD2*, Mithun V. Shah, MD, PhD2, Jeanne M. Palmer, MD3, Hemant S. Murthy, MD4, Mohamed A. Kharfan-Dabaja, MD, MBA5, Mark R. Litzow, MD2, James M. Foran, MD6 and Talha Badar, MD7

1Hematology and Oncology, Mayo Clinic, Jacksonville, FL
2Division of Hematology, Mayo Clinic, Rochester, MN
3Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
4Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL
5Mayo Clinic, Jacksonville, FL
6Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic Florida, Jacksonville, FL
7Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL

Thibault Comont, MD1,2*, Maël Heiblig, MD3*, Jeremie Dion, MD1*, Etienne Riviere, MD, PhD4*, Louis Terriou, MD5*, Julien Rossignol, MD, PhD6*, Virginie Rieu, MD7*, Guillaume Le Guenno, MD8*, Alexis Mathian, MD9*, Achille Aouba, MD, PhD10*, Julien Vinit, MD11*, Benjamin Terrier, MD, PhD12*, Olivier Kosmider, PharmD, PhD13*, Sophie Georgin-Lavialle, MD, PhD14*, Pierre Fenaux, MD, PhD15 and Arsene Mekinian, MD PhD16*

1IUCT Oncopole / Service de Médecine Interne et Immunopathologie, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
2Centre de Recherche en Cancérologie de Toulouse, UMR1037-INSERM, ERL5294 CNRS, Toulouse, France
3Centre Hospitalier Lyon Sud / Service d'Hématologie, Hospices Civils de Lyon, Pierre Bénite, France
4Hôpital Haut-Lévêque / Service de médecine interne, Centre Hospitalier Universitaire de Bordeaux, Pessac, FRA
5Service de Médecine Interne et Immunologie Clinique, Centre Hospitalier Universitaire de Lille, Lille, France
6Hopital Necker / Service d' Hématologie, Assistance Publique des Hôpitaux de Paris / French Reference Center for Mastocytosis (CEREMAST), Paris, France
7Centre Hospitalier Universitaire d'Estaing, Clermont-Ferrand, FRA
8Service de Médecine Interne, Centre Hospitalier Universitaire d'Estaing, Clermont Ferrand, France
9Hôpital Pitié-Salpêtrière / Service de Médecine Interne, Assistance Publique des Hopitaux de Paris, Paris, France
10Service de Médecine Interne, Centre Hospitalier Universitaire de Caen, CAEN, FRA
11Service de Médecine Interne, CH William Morey, Chalon sur Saône, France
12Service de Médecine interne, Assistance Publique des Hopitaux de Paris / Hôpital Cochin, Paris, FRA
13Laboratoire d'hématologie, Assistance Publique Hôpitaux de Paris / Hôpital Cochin, Paris, France
14Service de Medecine Interne, Assistance Publique des Hopitaux de Paris / Hopital Tenon / entre de Références des Maladies AutoInflammatoires et des Amyloses inflammatoires (CEREMAIA), France, France
15Service d'Hématologie, Assistance Publique des Hôpitaux de Paris/ Hôpital Saint-Louis / Université Paris 7, Paris, France
16Service de Medecine Interne, Assistance Publique des Hopitaux de Paris / Hôpital Saint Antoine, Paris, France

Scott C Howard, MD, MSc1, Ansu Kumar, M.Sc.2*, Michael Castro, MD2*, Himanshu Grover, M.S.2*, Subrat Mohapatra, M.Sc.2*, Shweta Kapoor, M.Sc.2*, Anuj Tyagi, M.Sc.2*, Prashant Ramachandran Nair, B.Tech.2*, Rakhi Purushothaman Suseela, B.Tech.2*, Anusha Pampana, M.Sc.2*, Deepak Anil Lala, B.Tech.2*, Divya Singh, M.Sc.2*, Vijayashree P Shyamasundar, M.Sc.2*, Shruthi Kulkarni, B.E.2*, Yugandhara Narvekar, M.Sc.2*, Kritika Sahni, PhD2*, Rahul K Raman, M.Sc.2*, Veena Balakrishnan, M.Sc.2*, Mamatha Patil, B.E2*, Naga Ganesh Palaniyeppa, B.Tech2*, Ashokraja Balla, M.Tech.2*, Sanjana Patel, MSc2*, Nirjhar Mundkur, B.S2*, James Christie, B.S.2*, Michele Dundas Macpherson, B.A.Sc.2* and Guido Marcucci, MD3

1Department of Acute and Tertiary Care, University of Tennessee Health Science Center, Memphis, TN
2Cellworks Group Inc., South San Francisco, CA
3Department of Hematological Malignancies Translational Science, Gehr Family Center for Leukemia Research, Hematology Malignancies and Stem Cell Transplantation Institute, Beckman Research Institute, City of Hope, Duarte, CA

Ahmad Nanaa, MD1, Aref Al-Kali, MD1, David S. Viswanatha, MD2, James M. Foran, MD3, Talha Badar, MD4, Lisa Z. Sproat, MD5, Rong He, MD6, Phuong L Nguyen, MD2, Dragan Jevremovic, MD, PhD2*, Mohamed E Salama, MD7, Patricia Greipp, DO2, Naseema Gangat, M.B.B.S1*, Ayalew Tefferi, MD1, Mark R. Litzow, MD1, Abhishek A. Mangaonkar, MBBS1, Mithun V. Shah, MD, PhD1, Mrinal M. Patnaik, MBBS1 and Hassan B. Alkhateeb, MD1*

1Division of Hematology, Mayo Clinic, Rochester, MN
2Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
3Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic Florida, Jacksonville, FL
4Division of Hematology and Oncology, Mayo Clinic, Florida
5Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
6Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
7Mayo Clinic, Rochester, MN

Shuhei Kurosawa1*, Yoshimitsu Shimomura2*, Hidehiro Itonaga, MD, PhD3*, Yuho Najima4, Takeshi Kobayashi4, Yukiyasu Ozawa5*, Yoshinobu Kanda6, Shinichi Kako7, Toshiro Kawakita8*, Ken-Ichi Matsuoka9, Yumiko Maruyama10*, Shuichi Ota11, Hideyuki Nakazawa12*, Kazunori Imada13*, Takafumi Kimura14*, Junya Kanda15, Takahiro Fukuda16*, Yoshiko Atsuta, MD, PhD17,18* and Ken Ishiyama19

1Division of Stem Cell and Molecular Medicine, Center for Stem Cell Biology and Regenerative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
2Department of Haematology, Kobe City Hospital Organization Kobe City Medical Centre General Hospital, Kobe, Japan
3Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan
4Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
5Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan
6Division of Hematology, Jichi Medical University, Shimotsuke, Japan
7Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan
8Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan
9Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
10Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan
11Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
12Department of Hematology, Shinshu University School of Medicine, Matsumoto, Japan
13Department of Hematology, Japanese Red Cross Osaka Hospital, Osaka, Japan
14Preparation Department, Japanese Red Cross Kinki Block Blood Center, Ibaraki, Japan
15Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
16Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan
17Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan
18Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan
19Department of Hematology, Kanazawa University Hospital, Kanazawa, Japan

Talha Badar, MD1, Ahmad Nanaa, MD2, Rong He, MD3, Aref Al-Kali, MD4, David S. Viswanatha, MD5, Emily Godsey6*, Lisa Z. Sproat, MD7, Mohamed A. Kharfan-Dabaja, MD, MBA8,9, Mrinal M. Patnaik, MBBS4, Hassan B. Alkhateeb, MD4*, Mark R. Litzow, MD4 and James M. Foran, MD10

1Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
2Division of Hematology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL
3Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
4Division of Hematology, Mayo Clinic, Rochester, MN
5Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
6Hematology and Oncology, Mayo Clinic, Jacksonville, FL
7Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
8Hematology and Oncology, Mayo Clinic, Florida
9Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, FL
10Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic Florida, Jacksonville, FL

Albert Kolomansky, MD1,2,3*, Roy Malka, MD4*, Johnathan Ben-Ezra, MD5*, Moria Rahamim6*, Edo Cohen-Karlik, MSc7*, Gal Barequet7*, Sagi Tauber7*, Itay Kalev7*, Ruben Wolhandler7*, Yoav Gaulan7*, Roee Esquira7*, Moni Shahar, PhD8*, Yishai Mansour, PhD7*, Amir Globerson, PhD7*, Drorit Neumann, PhD6, Moshe Mittelman, MD1,3 and Howard S. Oster, MD, PhD3

1Department of Hematology, Tel Aviv Sourasky Medical Center/Sackler Faculty of Medicine, Tel Aviv, Israel
2Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, TX, Israel
3Department of Internal Medicine A, Tel Aviv Sourasky Medical Center/Sackler Faculty of Medicine, Tel Aviv, Israel
4Department of Internal Medicine A, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
5Department of Pathology, Tel Aviv Sourasky Medical Center/Sackler Faculty of Medicine, Tel Aviv, Israel
6Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
7Department of Computer Science, Tel Aviv University, Tel Aviv, Israel
8Center for AI and Data Science (TAD), Tel Aviv University, Tel Aviv, Israel

Gabriele Todisco, MD1,2*, Maria Creignou, MD1*, Elsa Bernard, PhD3*, Ann-Charlotte Björklund1*, Pedro Luis Moura, PhD4*, Monika Jansson1*, David Chang1*, Sigita Venckute1*, Gunilla Walldin1*, Luca Malcovati, MD5, Bianca Tesi, MD6*, Teresa Mortera-Blanco, PhD1*, Indira Barbosa, BMA1*, Elli Papaemmanuil, PhD3 and Eva Hellstrom Lindberg, MD, PhD1

1Center for Hematology and Regenerative Medicine, Department of Medicine (MedH), Karolinska Institutet, Huddinge, Sweden
2University of Pavia, Department of Molecular Medicine, Pavia, Italy
3Computational Oncology Service, Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
4Center for Hematology and Regenerative Medicine, Department of Medicine (MedH), Karolinska Institutet, Huddinge, Stockholm, Sweden
5Department of Molecular Medicine & Hematology Oncology, University of Pavia & IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
6Department of Clinical Genetics, Karolinska Institutet, Stockholm, Sweden

Jennifer Vidler, MBBS, MRCP1*, Thanussuyah Alaguthurai, MSc2*, Sultan Abdul-Jawad, PhD2*, Sivalekha Viramuthu, MBBS3*, Richard Beatson, PhD2*, Rosalind Graham, PhD2*, Sheeba Irshad, MBBS, MRCP, PhD4*, Austin G. Kulasekararaj, MD, MBBS, FRCPath, MRCP5 and Piers EM Patten, MB, ChB, FRCP, FRCPath, PhD6

1Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, ENG, United Kingdom
2Comprehensive Cancer Centre, School of Cancer & Pharmaceutical Sciences, King's College London, London, United Kingdom
3GKT School of Medical Education, King's College, London, London, United Kingdom
4School of Cancer and Pharmaceutical Sciences, King's College, London, London, United Kingdom
5Department of Haematological Medicine, King's College Hospital‐NHS Foundation Trust, NIHR Wellcome Foundation Clinical Research Facility, King's College London, London, United Kingdom
6Comprehensive Cancer Centre, King's College London, London, United Kingdom

Arsène Mékinian1*, Lin-Pierre Zhao, MD2*, Kristell Desseaux3*, Rose Rose4*, Laurent Pascal, MD, PhD5*, Pierre Peterlin6*, Thibault Comont7*, Alexandre Maria8*, Louis Terriou, MD9*, Maud d'Aveni10*, Marie-Pierre Gourin, MD11*, Norbert Vey, MD12, Odile bayne Rouzy13*, Sophie Dimicoli Salazar14*, Anne Banos, MD15*, Stefan Wickenhauser16*, Benoit De Renzis, MD17*, Eric Durot18,19*, Shanti Ame20*, Laurent Voillat, MD21*, Fatiha Chermat22*, Anne Vekhoff, MD23*, Karine Lemaire24*, Vincent Jachiet25*, Sylvie Chevret, MD, PhD26*, Lionel Ades, MD, PhD27*, Olivier Fain, MD28* and Pierre Fenaux, MD, PhD29

1APHP, Hôpital Saint Antoine, Service d'Hématologie Clinique et de Thérapie cellulaire, Paris, France
2saint louis, Paris, France
3Kristell Desseaux , Kristell Desseaux , France
4lille, lille, France
5HOPITAL SAINT VINCENT, GHICL, Lille, FRA
6Clinical Hematology, HOPITAL HOTEL DIEU ET HME, NANTES CEDEX 1, France
7Comont Thibault , toulouse, France
8montpellier, paris, France
9Hôpital Claude Huriez, Lille, France
10Nancy hospital, hematological department, Nancy, France
11Department of Clinical Hematology, Limoges University Hospital, Limoges, France
12Institut Paoli Clamettes, Marseille, France
13toulose, toulouse, France
14abanos@ch-cotebasque.fr, Pessac, FRA
15HOSPITAL, COTE BASQUE, France
16HôPital Caremeau, Nimes Cedex 9, FRA
17Service d'Hématologie Clinique Adulte, Clermont Ferrand, FRA
18Service d'Hématologie, saint louis, Reims Cedex, France
19CHU Reims, Hôpital Robert Debré, Reims, France
20anne.vekhoff@aphp.fr, Strasbourg, FRA
21Laurent.Voillat@ch-chalon71.fr, g, France
22Groupe Francophone des Myélodysplasies (GFM), Paris, France
23Department of Clinical Hematology and Cellular Therapy, Saint Antoine Hospital, Assistance Publique - Hôpitaux de Paris, Sorbonne Université, Paris, France
24zaer, paris, France
25HôPital Saint Antoine, Paris, FRA
26APHP, Saint-Louis University Hospital, Department of Biostatistics, PARIS, France
27AP-HP, Hôpital Saint Louis and University of Paris, and INSERM U944, Paris, France
28int atnoine, saint antoine, paris, France
29Service d'Hématologie, Assistance Publique des Hôpitaux de Paris/ Hôpital Saint-Louis / Université Paris 7, Paris, France

Yael Haring1*, Nitzan Cohen Sagy, MS1*, Shaimaa Taha, BS1*, Albert Kolomansky, MD2,3,4*, Howard S. Oster, MD, PhD3 and Moshe Mittelman, MD3,4

1Department of Internal Medicine A, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
2Department of Cell and Developmental Biology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
3Department of Internal Medicine A, Tel Aviv Sourasky Medical Center/Sackler Faculty of Medicine, Tel Aviv, Israel
4Department of Hematology, Tel Aviv Sourasky Medical Center/Sackler Faculty of Medicine, Tel Aviv, Israel

Yuli Cai1*, Jingliao Zhang, MD2, Meihui Yi1*, Xiaoming Liu1*, Xiaoyan Zhang1*, Yang Wan3*, Lixian Chang, ph D1*, Li Zhang4*, Xiaojuan Chen, MD5*, Ye Guo, MD1*, Yao Zou, MD1*, Yumei Chen, MD1*, Yingchi Zhang, PhD6*, Wenyu Yang, MD1* and Xiaofan Zhu, MD1

1Division of Pediatric Blood Diseases Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China, Tianjin, China
2Division of Pediatric Blood Diseases Center, Memphis, TN
3Division of Pediatric Blood diseases Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China, Tianjin, China
4Division of Pediatric Blood Diseases Center, State Key Laboratory of Experimenta Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
5Division of Pediatric Blood Disease Center, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
6Division of Pediatric Blood Diseases Center, State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital and Center for Stem Cell Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China

Annika Kasprzak, MD1*, Sandra Becker2*, Martina Rudelius, MD3*, Corinna Strupp, MD1*, Kathrin Nachtkamp, MD1*, Judith Strapatsas, MD1*, Barbara Hildebrandt4*, Norbert Gattermann, MD1 and Ulrich Germing, MD1*

1Dept. of Hematology, Oncology and Clinical Immunology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
2Dept. of Hematology, Oncology and Clinical Immunology, Heinrich Heine University Düsseldorf, Duesseldorf, Germany
3Institute of Pathology, University Hospital, LMU Munich, Munich, Germany
4Institute of Human Genetics, Heinrich Heine University Düsseldorf, Düsseldorf, Germany

Jan Philipp Bewersdorf, MD1, Wei Wei, MD2*, Anna Jaiani3*, Prital Patel3*, Rajni Mehta3*, Natalia Neparidze, MD4,5, Rory M. Shallis, MD6, Nikolai Podoltsev, MD, PhD4,5, Andrew M. Brunner, MD7,8 and Amer M. Zeidan, MD4,9

1Department of Internal Medicine, YALE UNIVERSITY SCHOOL OF MEDICINE, New Haven, CT
2Department of Biostatistics, Yale School of Public Health, New Haven, CT
3Yale University, New Haven
4Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University School of Medicine, New Haven, CT
5Yale University School of Medicine, New Haven, CT
6Hematology, Yale University School of Medicine, New Haven, CT
7Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
8Dana-Farber Cancer Institute, Boston, MA
9Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, East Haven, CT

Rakchha Chhetri, MBBS1,2*, Kirsty Sharplin3*, William Proudman4*, Monika M Kutyna, MSc1,5*, Siddarth Nayar, MBBS6*, Deepak Singhal, MBBS, MD, FRACP, FRCPA5,7, David M Ross, MBBS, PhD, FRACP, FRCPA4,7,8,9,10*, Michelle Damin, MBBS, FRACP, FRCPA11*, Akash Kalro, MD12*, Peter G Bardy, MBBS, FRACP, FRCPA, FRCPath4,13,14*, Daniel Thomas, MD, PhD15,16,17, Mithun V. Shah, MD, PhD18,19 and Devendra Hiwase, MBBS, MD, FRACP, FRCPA, PhD5,8,20,21

1Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
2Department of Haematology, Central Adelaide Local Health Network, Adelaide, SA, Australia
3Haematology and Stem Cell Transplantation, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
4Adelaide Medical School, University of Adelaide, Adelaide, Australia
5Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia
6Department of Hematology, Central Adelaide Local Health Network, Adelaide, SA, AUS
7Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
8Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia
9Department of Haematology, Flinders Medical Centre, Bedford Park, Australia
10Department of Haematology, Flinders Medical Centre and University, Adelaide, SA, Australia
11Lyell McEwin Hospital, Elizabeth Vale, AUS
12Department of Haematology, Central Adelaide Local Health Network, Adelaide, SA, AUS
13The Queen Elizabeth Hospital, Woodville, Australia
14Royal Adelaide Hospital, Adelaide, SA, Australia
15Precision Medicine Theme, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia
16Department of Medicine, Division of Hematology, Stanford University, Stanford, CA
17Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia
18Division of Hematology, Mayo Clinic, Rochester, MN
19Department of Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Rochester, MN
20Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia
21Department of Haematology, SA Pathology, Adelaide, Australia

Smith Kungwankiattichai, MD1*, BEN Ponvilawan, MD2*, Claudie Roy, MD3*, Pattaraporn Tunsing, BNS4*, Florian Kuchenbauer, MD, PhD5 and Weerapat Owattanapanich, MD4*

1Division of Hematology, Faculty of Medicine Siriraj Hospital, Bangkok, Thailand
2Siriraj Center of Research Excellence (SiCORE) for Systems Pharmacology, Department of Pharmacology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
3Leukemia/Bone Marrow Transplantation Program of BC, Vancouver, Canada
4Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
5BC Cancer, Leukemia/BMT Program of British Columbia, Vancouver, BC, Canada

Sai Prasad Prasad Desikan, MD1*, Guillermo Montalban-Bravo, MD2, Maro Ohanian, DO2*, Naval Daver, MD3, Musa Yilmaz, MD2, Marina Konopleva, MD, PhD2, Tapan M. Kadia, MD4, Sangeetha Venugopal, MD2, Heather Schneider, BSN, RN5*, Kelly S. Chien, MD2, Rashmi Kanagal-Shamanna, MD6, Hagop Kantarjian, MD2 and Guillermo Garcia-Manero, MD2

1Leukemia, MD Anderson, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
5Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX

Michael Daunov, DO1, Howard Meyerson, MD2*, Kwadwo Asare Oduro Jr., MD, PhD3, Christopher B Ryder, MD, PhD4,5, Navid Sadri, MD6*, Jennifer Yoest, MD7*, Shufen Cao8*, Pingfu Fu, PhD9*, Rose Beck, MD, PhD2* and Benjamin Tomlinson, MD8,10

1University Hospitals Cleveland Medical Center, Cleveland, OH
2Department of Hematopathology, University Hospitals Cleveland Medical Center, Cleveland, OH
3Department of Hematopathology, University Hospitals Cleveland Medical Center & Case Western Reserve University, Cleveland, OH
4Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH
5Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH
6University Hospitals Cleveland Medical Center, Department of Pathology, Cleveland, OH
7Division of Genomic and Molecular Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH
8Case Western Reserve University, Cleveland, OH
9Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH
10Division of Hematology and Oncology, University Hospitals Case Comprehensive Cancer Center, Cleveland, OH

Guillermo Garcia-Manero, MD1, Naval Daver, MD1, Jin Xu, PhD2*, Mark Chao, MD, PhD2, Trisha Chung, BS2*, Anderson Tan, PharmD, Rph2*, Yan V. Wang, Phd, MPH, MSE2*, Andrew H. Wei, MBBS, PhD3, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath4 and David A. Sallman, MD5

1The University of Texas MD Anderson Cancer Center, Houston, TX
2Gilead Sciences, Inc., Foster City, CA
3The Alfred Hospital and Monash University, Melbourne, VIC, Australia
4University of Oxford, Oxford, United Kingdom
5Moffitt Cancer Center, Tampa, FL

Guillermo Garcia-Manero, MD1, Matteo G. Della Porta, MD2*, Ekatherine Asatiani, MD3, Francis Seguy, MSc3*, Feng Zhou, PhD4* and Jean-Marie Michot, MD5*

1MD Anderson Cancer Center, Houston, TX
2Humanitas University, Pieve Emanuele MI, Italy
3Incyte Biosciences International Sàrl, Morges, Switzerland
4Incyte Corporation, Wilmington, DE
5Gustave Roussy Cancer Center, Villejuif, France

*signifies non-member of ASH